Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Evaluation of Different Bulk-Fill Restorative Materials in Primary Molars

NCT: NCT07868016 · NOT_YET_RECRUITING

NCT IDNCT07868016
StatusNOT_YET_RECRUITING
Start Date2026-10-30
Completion2027-04-30
SponsorBurak Carıkcıoglu (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to compare the clinical performance of chemically-cured and light-cured bulk-fill composite materials used for Class II restorations in children aged 4 to 9 years with primary second molars. The main questions it aims to answer are: What are the clinical success rates of the restorations at 12 months based on modified FDI criteria? How do the two materials compare regarding application times, clinician ease of use, and patient satisfaction? Researchers will compare the chemically-cured bulk-fill composite (Stela Capsule) to the light-cured bulk-fill composite (Filtek One) using a split-mouth design to see which material provides better long-term clinical performance and survival rates. Participants will: Receive two different bulk-fill composite restorations in matched primary second molars within the same dental arch Visit the clinic for routine checkups and evaluations at 1 week, 3 months, 6 months, 12 months, 24 months, and 36 months

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑